Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Charissa Wijnands, Somayya Noori, Niels W. C. J. van de Donk, Martijn M. VanDuijn & Joannes F. M. Jacobs. (2023) Advances in minimal residual disease monitoring in multiple myeloma. Critical Reviews in Clinical Laboratory Sciences 0:0, pages 1-17.
Read now
Read now
Alessandro Stecco, Francesco Buemi, Antoine Iannessi, Alessandro Carriero & Andrea Gallamini. (2018) Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma. Leukemia & Lymphoma 59:11, pages 2546-2556.
Read now
Read now
Elisabet E. Manasanch & Ola Landgren. (2016) Myeloma imaging: time to move on!. Leukemia & Lymphoma 57:7, pages 1499-1500.
Read now
Read now
Silvia Mangiacavalli, Sara Pezzatti, Fausto Rossini, Elisa Doni, Federica Cocito, Silvia Bolis & Alessandro Corso. (2016) Implemented myeloma management with whole-body low-dose CT scan: a real life experience. Leukemia & Lymphoma 57:7, pages 1539-1545.
Read now
Read now
Karma Z Salem & Irene M Ghobrial. (2015) The road to cure in multiple myeloma starts with smoldering disease. Expert Opinion on Orphan Drugs 3:6, pages 653-661.
Read now
Read now
Articles from other publishers (77)
Thaiza Goncalves Rocha, Carla Barros de Oliveira, Roberto José Pessoa de Magalhães Filho, Angelo Maiolino, Marcela Baraúna Magno, Davi da Silva Barbirato, Eduardo Murad Villoria, Lucianne Cople Maia, Sandra Regina Torres & Maria Augusta Visconti. (2023) Comparison between computed tomography and magnetic resonance imaging in detecting multiple myeloma lesions in the skull: A systematic review. Clinical and Translational Imaging.
Crossref
Crossref
Dong Kyun Kim, Joon-Yong Jung, Hyeonseon Kim, Sungwon Lee, So-Yeon Lee, Seungeun Lee, Sung-Soo Park & Chang‐Ki Min. (2023) Development of a Semiquantitative Whole-Body MRI Scoring System for Multiple Myeloma. Radiology 308:3.
Crossref
Crossref
Jens Hillengass, Tom Martin, Noemi Puig, Bruno Paiva, Saad Usmani, Shaji Kumar & Jesus San-Miguel. (2023) Disease Monitoring In Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 23:4, pages 244-248.
Crossref
Crossref
A. M. Danilina, L. P. Mendeleeva, I. E. Kostina, E. O. Gribanova, V. V. Ryzhko & Ya. B. Bal'zhanova. (2023) Whole-body low-dose computed tomography in primary patients with multiple myeloma. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 13:2, pages 62-69.
Crossref
Crossref
Won-Jong BahkWon-Jong Bahk. 2023. Diagnosis and Management of Primary Bone Tumors. Diagnosis and Management of Primary Bone Tumors
87
114
.
Linqing Shi, Bo Chen, Tianyu Liu, Liqiang Li, Biao Hu, Chenzhen Li, Bing Jia & Fan Wang. (2022)
99m
Tc-CD3813: A Nanobody-Based Single Photon Emission Computed Tomography Radiotracer with Clinical Potential for Myeloma Imaging and Evaluation of CD38 Expression
. Molecular Pharmaceutics 19:7, pages 2583-2594.
Crossref
Crossref
Joana Caetano, Filipa Barahona, Paulo Lúcio & Cristina João. (2022) Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?. Hemato 3:3, pages 385-413.
Crossref
Crossref
Sharath Rama, Chong Hyun Suh, Kyung Won Kim, Jared C. Durieux, Nikhil H. Ramaiya & Sree Harsha Tirumani. (2022) Comparative Performance of Whole-Body MRI and FDG PET/CT in Evaluation of Multiple Myeloma Treatment Response: Systematic Review and Meta-Analysis. American Journal of Roentgenology 218:4, pages 602-613.
Crossref
Crossref
Renyang Gu, Ashik Amlani, Ulrike Haberland, Dan Hodson, Matthew Streetly, Michela Antonelli, Isabel Dregely & Vicky Goh. (2022) Correlation between whole skeleton dual energy CT calcium-subtracted attenuation and bone marrow infiltration in multiple myeloma. European Journal of Radiology 149, pages 110223.
Crossref
Crossref
Esther Mena, Evrim B. Turkbey & Liza Lindenberg. (2022) Modern radiographic imaging in multiple myeloma, what is the minimum requirement?. Seminars in Oncology 49:1, pages 86-93.
Crossref
Crossref
N. S. Lutsik, L. P. Mendeleeva & G. A. Yatsik. (2022) Informative value of whole-body magnetic resonance imaging with diffusion-weighted images for the detection of bone marrow infiltration in patients with multiple myeloma (literature review). Oncohematology 17:1, pages 87-94.
Crossref
Crossref
Frederic E. Lecouvet, Marie-Christiane Vekemans, Thomas Van Den Berghe, Koenraad Verstraete, Thomas Kirchgesner, Souad Acid, Jacques Malghem, Joris Wuts, Jens Hillengass, Vincent Vandecaveye, François Jamar, Olivier Gheysens & Bruno C. Vande Berg. (2021) Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT. Skeletal Radiology 51:1, pages 59-80.
Crossref
Crossref
Karla M. Treitl, Jens Ricke & Andrea Baur-Melnyk. (2021) Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging. Skeletal Radiology 51:1, pages 43-58.
Crossref
Crossref
Gayane Aghakhanyan, Martina Sollini, Sara Galimberti, Roberta Zanca, Roberto Boni, Enrica Esposito, Francesco Bartoli & Paola A. Erba. 2020. Nuclear Oncology. Nuclear Oncology
1
53
.
Gayane Aghakhanyan, Martina Sollini, Sara Galimberti, Roberta Zanca, Roberto Boni, Enrica Esposito, Francesco Bartoli & Paola A. Erba. 2022. Nuclear Oncology. Nuclear Oncology
475
527
.
M. Guedj, D. Momboisse, C. Role, Q. Brana & A. Boisson. (2021) Découverte fortuite d’une récivide myélomateuse lors d’une scintigraphie osseuse réalisée dans le cadre d’une suspicion d’algodystrophie. Médecine Nucléaire 45:5-6, pages 289-292.
Crossref
Crossref
Fangbai WuStephanie BernardLaura M. FayadHakan IlaslanChristina MessiouLia Angela MoulopoulosMichael E. Mulligan. (2021)
Updates and Ongoing Challenges in Imaging of Multiple Myeloma:
AJR
Expert Panel Narrative Review
. American Journal of Roentgenology 217:4, pages 775-785.
Crossref
Crossref
Davide Ippolito, Teresa Giandola, Cesare Maino, Davide Gandola, Maria Ragusi, Paolo Brambilla, Pietro Andrea Bonaffini & Sandro Sironi. (2021) Diagnostic Value of Whole-Body MRI Short Protocols in Bone Lesion Detection in Multiple Myeloma Patients. Diagnostics 11:6, pages 1053.
Crossref
Crossref
Davide Ippolito, Teresa Giandola, Cesare Maino, Davide Gandola, Maria Ragusi, Pietro Andrea Bonaffini & Sandro Sironi. (2021) Whole Body Low Dose Computed Tomography (WBLDCT) Can Be Comparable to Whole-Body Magnetic Resonance Imaging (WBMRI) in the Assessment of Multiple Myeloma. Diagnostics 11:5, pages 857.
Crossref
Crossref
Kota Yokoyama, Junichi Tsuchiya & Ukihide Tateishi. (2021) Comparison of [18F]FDG PET/CT and MRI for Treatment Response Assessment in Multiple Myeloma: A Meta-Analysis. Diagnostics 11:4, pages 706.
Crossref
Crossref
R. Gallicchio, A. Nardelli, G. Calice, A. Guarini, G. Guglielmi & G. Storto. (2021) F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study. European Journal of Radiology 136, pages 109564.
Crossref
Crossref
Benjamin T. Diamond, Even Rustad, Kylee Maclachlan, Katie Thoren, Caleb Ho, Mikhail Roshal, Gary A. Ulaner & C. Ola Landgren. (2021) Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity. Blood Reviews 46, pages 100732.
Crossref
Crossref
Daria Maccora, Carmelo Caldarella, Silvia Taralli, Valentina Scolozzi, Margherita Lorusso, Fabrizio Cocciolillo & Maria Lucia Calcagni. (2021) Diagnostic role of 11C-methionine PET/CT in patients with multiple myeloma and other plasma cell malignancy: a literature review. Clinical and Translational Imaging 9:1, pages 3-17.
Crossref
Crossref
嘉宁 杜. (2021) Advances in Imaging Studies of Multiple Myeloma. Advances in Clinical Medicine 11:08, pages 3474-3480.
Crossref
Crossref
Sébastien Mulé, Edouard Reizine, Paul Blanc-Durand, Laurence Baranes, Pierre Zerbib, Robert Burns, Refaat Nouri, Emmanuel Itti & Alain Luciani. (2020) Whole-Body Functional MRI and PET/MRI in Multiple Myeloma. Cancers 12:11, pages 3155.
Crossref
Crossref
Francesca Di Giuliano, Eliseo Picchi, Massimo Muto, Antonello Calcagni, Valentina Ferrazzoli, Valerio Da Ros, Silvia Minosse, Agostino Chiaravalloti, Francesco Garaci, Roberto Floris & Mario Muto. (2020) Radiological imaging in multiple myeloma: review of the state-of-the-art. Neuroradiology 62:8, pages 905-923.
Crossref
Crossref
Gary A. Ulaner, Nicholas B. SobolJoseph A. O’Donoghue, Assen S. Kirov, Christopher C. Riedl, Ryan Min, Eric SmithLukas M. Carter, Serge K. LyashchenkoJason S. Lewis & C. Ola Landgren. (2020) CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging. Radiology 295:3, pages 606-615.
Crossref
Crossref
Vanessa Pfahler, Melvin D'Anastasi, Hans‐Roland Dürr, Regina Schinner, Jens Ricke & Andrea Baur‐Melnyk. (2020) Tumor load in patients with multiple myeloma: β₂‐microglobulin levels versus low‐dose whole‐body CT. European Journal of Haematology 104:5, pages 383-389.
Crossref
Crossref
Gary A. Ulaner & C. Ola Landgren. (2020) Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders. Best Practice & Research Clinical Haematology 33:1, pages 101148.
Crossref
Crossref
Stefania Oliva, Mattia D'Agostino, Mario Boccadoro & Alessandra Larocca. (2020) Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma. Frontiers in Oncology 10.
Crossref
Crossref
Iryna V. Baranova, Kateryna P. Postovitenko, Iryna A. Iliuk, Sergii P. Kolisnyk, Alla F. Gumeniuk, Vitalii L. Katiukha, Olena V. Dolynna & Iryna V. Kurylenko. (2020) MULTIPLE MYELOMA: CHALLENGES OF DIFFERENTIAL DIAGNOSIS (CLINICAL CASE). Wiadomości Lekarskie 73:1, pages 203-207.
Crossref
Crossref
Alexandre Detappe, Mairead Reidy, Yingjie Yu, Clelia Mathieu, Hung V.-T. Nguyen, Thibaud P. Coroller, Fred Lam, Petr Jarolim, Peter Harvey, Andrea Protti, Quang-De Nguyen, Jeremiah A. Johnson, Yannick Cremillieux, Olivier Tillement, Irene M. Ghobrial & P. Peter Ghoroghchian. (2019) Antibody-targeting of ultra-small nanoparticles enhances imaging sensitivity and enables longitudinal tracking of multiple myeloma. Nanoscale 11:43, pages 20485-20496.
Crossref
Crossref
M V Solovev, L P Mendeleeva, M V Firsova, I P Aslanidi, O V Mukhortova & V G Savchenko. (2019) PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients. Terapevticheskii arkhiv 91:7, pages 75-82.
Crossref
Crossref
Sergey Kozyrev, Daniil Korabelnikov, Vasiliy Pop, Vladimir Troyan & Oleg Rukavicyn. (2019) Imaging in diagnostics and management of extramedullary lesions in a patient with multiple myeloma. Russian Medical and Social Journal 1:1, pages 74-87.
Crossref
Crossref
Alípio G. Ormond Filho, Bruno C. Carneiro, Daniel Pastore, Igor P. Silva, Sâmia R. Yamashita, Flávio D. Consolo, Vânia T. M. Hungria, Alex F. Sandes, Edgar G. Rizzatti & Marcelo A. C. Nico. (2019) Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria. RadioGraphics 39:4, pages 1077-1097.
Crossref
Crossref
Jens Hillengass, Saad Usmani, S Vincent Rajkumar, Brian G M Durie, María-Victoria Mateos, Sagar Lonial, Cristina Joao, Kenneth C Anderson, Ramón García-Sanz, Eloísa Riva, Juan Du, Niels van de Donk, Jesús G Berdeja, Evangelos Terpos, Elena Zamagni, Robert A Kyle, Jesús San Miguel, Hartmut Goldschmidt, Sergio Giralt, Shaji Kumar, Noopur Raje, Heinz Ludwig, Enrique Ocio, Rik Schots, Hermann Einsele, Fredrik Schjesvold, Wen-Ming Chen, Niels Abildgaard, Brea C Lipe, Dominik Dytfeld, Baldeep Mona Wirk, Matthew Drake, Michele Cavo, Juan José Lahuerta & Suzanne Lentzsch. (2019) International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. The Lancet Oncology 20:6, pages e302-e312.
Crossref
Crossref
Christina Messiou, Jens Hillengass, Stefan Delorme, Frédéric E. Lecouvet, Lia A. Moulopoulos, David J. Collins, Matthew D. Blackledge, Niels Abildgaard, Brian Østergaard, Heinz-Peter Schlemmer, Ola Landgren, Jon Thor Asmussen, Martin F. Kaiser & Anwar Padhani. (2019) Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology 291:1, pages 5-13.
Crossref
Crossref
Wende N. Gibbs, Kambiz Nael, Amish H. Doshi & Lawrence N. Tanenbaum. (2019) Spine Oncology. Radiologic Clinics of North America 57:2, pages 377-395.
Crossref
Crossref
Shalin Kothari, Jens Hillengass, Philip L. McCarthy & Sarah A. Holstein. (2019) Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?. Current Hematologic Malignancy Reports 14:1, pages 39-46.
Crossref
Crossref
Eugenio Salizzoni, Alberto Conficoni & Manuela Coe. 2019. Molecular Imaging in Multiple Myeloma. Molecular Imaging in Multiple Myeloma
39
72
.
Chao Wu, Juan Huang, Wen-Bin Xu, Yong-Jing Guan, Hua-Wei Ling, Jian-Qing Mi & Hua Yan. (2018) Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient. Academic Radiology 25:7, pages 904-914.
Crossref
Crossref
Dimitrios C. Karampinos, Stefan Ruschke, Michael Dieckmeyer, Maximilian Diefenbach, Daniela Franz, Alexandra S. Gersing, Roland Krug & Thomas Baum. (2018) Quantitative MRI and spectroscopy of bone marrow. Journal of Magnetic Resonance Imaging 47:2, pages 332-353.
Crossref
Crossref
Jens Hillengass, Maximilian Merz & Stefan Delorme. (2018) Minimal residual disease in multiple myeloma: use of magnetic resonance imaging. Seminars in Hematology 55:1, pages 19-21.
Crossref
Crossref
Evangelos Terpos & Nikolaos Kanellias. 2018. Personalized Therapy for Multiple Myeloma. Personalized Therapy for Multiple Myeloma
131
167
.
Evangelos Terpos, Nikolaos Kanellias & Noopur Raje. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms
111
140
.
Noemi Puig, Carmela Palladino, Bruno Paiva & Marco Ladetto. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms
97
109
.
Jonathan P. Groß, Johanna Nattenmüller, Stefan Hemmer, Diana Tichy, Julia Krzykalla, Hartmut Goldschmidt, Uta Bertsch, Stefan Delorme, Hans-Ulrich Kauczor, Jens Hillengass & Maximilian Merz. (2017) Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trial. Oncotarget 8:40, pages 68460-68471.
Crossref
Crossref
Leo Rasche, Edgardo AngtuacoJames E. McDonaldAmy Buros, Caleb Stein, Charlotte PawlynSharmilan Thanendrarajan, Carolina Schinke, Rohan SamantShmuel Yaccoby, Brian A. Walker, Joshua Epstein, Maurizio Zangari, Frits van Rhee, Tobias MeissnerHartmut GoldschmidtKari Hemminki, Richard HoulstonBart Barlogie, Faith E. Davies, Gareth J. Morgan & Niels Weinhold. (2017) Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma. Blood 130:1, pages 30-34.
Crossref
Crossref
Julie C. Dutoit & Koenraad L. Verstraete. (2017) Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma. Skeletal Radiology 46:6, pages 733-750.
Crossref
Crossref
Martina Sollini, Sara Galimberti, Roberto Boni & Paola Anna Erba. 2017. Nuclear Oncology. Nuclear Oncology
395
433
.
Martina Sollini, Sara Galimberti, Roberto Boni & Paola Anna Erba. 2017. Nuclear Oncology. Nuclear Oncology
1
39
.
Manisha Bhutani, Saad Z. Usmani, Alankrita Taneja & Ola Landgren. (2016) Imaging Measurable (Minimal) Residual Disease in Multiple Myeloma. Current Radiology Reports 4:12.
Crossref
Crossref
Ola Landgren & S. Vincent Rajkumar. (2016) New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma. Clinical Cancer Research 22:22, pages 5428-5433.
Crossref
Crossref
Barry Amos, Amit Agarwal & Sangam Kanekar. (2016) Imaging of Multiple Myeloma. Hematology/Oncology Clinics of North America 30:4, pages 843-865.
Crossref
Crossref
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, Brian Durie, Ola Landgren, Philippe Moreau, Nikhil Munshi, Sagar Lonial, Joan Bladé, Maria-Victoria Mateos, Meletios Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans E Johnsen, Evangelos Terpos, Anthony Reiman, Robert A Kyle, Pieter Sonneveld, Paul G Richardson, Philip McCarthy, Heinz Ludwig, Wenming Chen, Michele Cavo, Jean-Luc Harousseau, Suzanne Lentzsch, Jens Hillengass, Antonio Palumbo, Alberto Orfao, S Vincent Rajkumar, Jesus San Miguel & Herve Avet-Loiseau. (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. The Lancet Oncology 17:8, pages e328-e346.
Crossref
Crossref
Julie C. Dutoit & Koenraad L. Verstraete. (2016) MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings. Insights into Imaging 7:4, pages 553-569.
Crossref
Crossref
S. Vincent Rajkumar. (2016) Updated Diagnostic Criteria and Staging System for Multiple Myeloma. American Society of Clinical Oncology Educational Book:36, pages e418-e423.
Crossref
Crossref
Giuseppe Rubini, Artor Niccoli-Asabella, Cristina Ferrari, Vito Racanelli, Nicola Maggialetti & Francesco Dammacco. (2016) Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques. Critical Reviews in Oncology/Hematology 101, pages 169-183.
Crossref
Crossref
Hakan Ilaslan & Murali SundaramHakan Ilaslan & Murali Sundaram. 2016. Pediatric and Adult MRI Atlas of Bone Marrow. Pediatric and Adult MRI Atlas of Bone Marrow
99
141
.
Martina Sollini, Sara Galimberti, Roberto Boni & Paola Anna Erba. 2016. Nuclear Oncology. Nuclear Oncology
1
39
.
Ik-Chan Song, Ji-Na Kim, Yoon-Seok Choi, Haewon Ryu, Myung-Won Lee, Hyo-Jin Lee, Hwan-Jung Yun, Samyong Kim, Soon Tae Kwon & Deog-Yeon Jo. (2014) Diagnostic and Prognostic Implications of Spine Magnetic Resonance Imaging at Diagnosis in Patients with Multiple Myeloma. Cancer Research and Treatment 47:3, pages 465-472.
Crossref
Crossref
N. Withofs, C. Nanni, P. Simoni, S. Fanti, Y. Beguin & J. Caers. (2015) Imaging myeloma and related monoclonal plasma cell disorders using MRI, low-dose whole-body CT and FDG PET/CT. Clinical and Translational Imaging 3:2, pages 95-109.
Crossref
Crossref
Meletios A. DimopoulosJens HillengassSaad UsmaniElena ZamagniSuzanne LentzschFaith E. DaviesNoopur RajeOrhan SezerSonja ZweegmanJatin ShahAshraf BadrosKazuyuki ShimizuPhilippe MoreauChor-Sang ChimJuan José LahuertaJian HouArtur JurczyszynHartmut GoldschmidtPieter SonneveldAntonio PalumboHeinz LudwigMichele CavoBart BarlogieKenneth AndersonG. David RoodmanS. Vincent RajkumarBrian G.M. DurieEvangelos Terpos. (2015) Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement. Journal of Clinical Oncology 33:6, pages 657-664.
Crossref
Crossref
Matthew J. Pianko, Evangelos Terpos, G. David Roodman, Chaitanya R. Divgi, Sonja Zweegman, Jens Hillengass & Suzanne Lentzsch. (2014) Whole-Body Low-Dose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease. Clinical Cancer Research 20:23, pages 5888-5897.
Crossref
Crossref
Charles Mesguich, Reza Fardanesh, Lawrence Tanenbaum, Ajai Chari, Sundar Jagannath & Lale Kostakoglu. (2014) State of the art imaging of multiple myeloma: Comparative review of FDG PET/CT imaging in various clinical settings. European Journal of Radiology 83:12, pages 2203-2223.
Crossref
Crossref
Irene M. Ghobrial & Ola Landgren. (2014) How I treat smoldering multiple myeloma. Blood 124:23, pages 3380-3388.
Crossref
Crossref
S Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar, Jens Hillengass, Efstathios Kastritis, Paul Richardson, Ola Landgren, Bruno Paiva, Angela Dispenzieri, Brendan Weiss, Xavier LeLeu, Sonja Zweegman, Sagar Lonial, Laura Rosinol, Elena Zamagni, Sundar Jagannath, Orhan Sezer, Sigurdur Y Kristinsson, Jo Caers, Saad Z Usmani, Juan José Lahuerta, Hans Erik Johnsen, Meral Beksac, Michele Cavo, Hartmut Goldschmidt, Evangelos Terpos, Robert A Kyle, Kenneth C Anderson, Brian G M Durie & Jesus F San Miguel. (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. The Lancet Oncology 15:12, pages e538-e548.
Crossref
Crossref
Noopur Raje, Beth Faiman, R. Donald Harvey, Sandra E. Kurtin, Sagar Lonial, Shaji K. Kumar, Adam D. Cohen, Miguel A. Conde, Sergio A. Giralt, Marie Sabo Recine, Eugene R. Tombler, Edward Stadtmauer, Sundar Jagannath & Kenneth C. Anderson. (2014) Identifying Professional Education Gaps and Barriers in Multiple Myeloma Patient Care: Findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee. Clinical Lymphoma Myeloma and Leukemia 14:5, pages 356-369.
Crossref
Crossref
Raymond L. Comenzo. (2014) Plasma Cell Neoplasms, Their Precursor States, and Their Prediction of Organ Damage. Journal of Clinical Oncology 32:25, pages 2679-2682.
Crossref
Crossref
M Merz, T Hielscher, B Wagner, S Sauer, S Shah, M S Raab, A Jauch, K Neben, D Hose, G Egerer, M-A Weber, S Delorme, H Goldschmidt & J Hillengass. (2014) Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma. Leukemia 28:9, pages 1902-1908.
Crossref
Crossref
Neha Korde, Sham Mailankody & Ola Landgren. (2014) The Road to Treating Smoldering Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 14, pages S59-S64.
Crossref
Crossref
Christopher S. Hourigan, Philip McCarthy & Marcos de Lima. (2014) Reprint of: Back to the Future! The Evolving Role of Maintenance Therapy after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 20:2, pages S8-S17.
Crossref
Crossref
Christopher S. Hourigan, Philip McCarthy & Marcos de Lima. (2014) Back to the Future! The Evolving Role of Maintenance Therapy after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 20:2, pages 154-163.
Crossref
Crossref
Nishant Tageja, Elisabet E. Manasanch, Neha Korde, Mary Kwok, Sham Mailankody, Manisha Bhutani, Mark Roschewski & Ola Landgren. (2014) Smoldering multiple myeloma: present position and potential promises. European Journal of Haematology 92:1, pages 1-12.
Crossref
Crossref
Katharina Lückerath, Constantin Lapa, Annika Spahmann, Gerhard Jörg, Samuel Samnick, Andreas Rosenwald, Herrmann Einsele, Stefan Knop & Andreas K. Buck. (2013) Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology. PLoS ONE 8:12, pages e84840.
Crossref
Crossref
Ola Landgren. (2013) Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies. Hematology 2013:1, pages 478-487.
Crossref
Crossref
Michael Mulligan. (2013) Imaging of myeloma: beyond lytic lesions. International Journal of Hematologic Oncology 2:6, pages 497-507.
Crossref
Crossref